New York State Common Retirement Fund’s SELLAS Life Sciences SLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$979K Buy
66,300
+27,300
+70% +$188K ﹤0.01% 1759
2026
Q1
$165K Buy
39,000
+32,100
+465% +$144K ﹤0.01% 2309
2025
Q4
$26K Sell
6,900
-42,400
-86% -$82.4K ﹤0.01% 3050
2025
Q3
$79.4K Hold
49,300
﹤0.01% 2757
2025
Q2
$108K Buy
+49,300
New +$75.7K ﹤0.01% 2539
2017
Q2
Sell
-5
Closed -$5K 3226
2017
Q1
$5K Hold
5
﹤0.01% 3134
2016
Q4
$14K Buy
+5
New +$29.1K ﹤0.01% 3109

Other funds holding SLS

New York State Common Retirement Fund's SLS Position: Q2 2026 in Review

New York State Common Retirement Fund increased its SELLAS Life Sciences (SLS) stake by 70% in Q2 2026, buying an estimated $188K and bringing the position to 66,300 shares worth $979K. The position accounts for ﹤0.01% of the portfolio, ranked #1759.

New York State Common Retirement Fund first reported a position in SLS in Q4 2016 and has held it in 7 quarters since. 61 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • New York State Common Retirement Fund held 66,300 shares of SELLAS Life Sciences worth $979K as of Q2 2026.
  • New York State Common Retirement Fund bought 27,300 SELLAS Life Sciences shares in Q2 2026, an estimated $188K.
  • SELLAS Life Sciences made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1759 holding.
  • New York State Common Retirement Fund first reported a position in SELLAS Life Sciences in Q4 2016 and has held it in 7 quarters since.
  • 61 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.